Noninvasive Skin Spectroscopy for Diabetes Screening
NCT00358254 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2010-07-22
Summary
The objective of this study is to assess the performance of a noninvasive device for the early screening of Diabetes Mellitus.
Conditions
- Prediabetic State
- Diabetes Mellitus, Type 2
Sponsors & Collaborators
-
VeraLight, Inc.
collaborator INDUSTRY -
InLight Solutions
lead INDUSTRY
Principal Investigators
-
Mark Rohrscheib, M.D. · UNMHSC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-10-31
- Completion
- 2007-12-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of SCOUT DS in Subjects With Type 2 Diabetes
NCT01346033 ·Status: COMPLETED
-
Point-of-Care Testing in Outpatient Diabetes Care
NCT06684990 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Pivotal Clinical Investigation Confirming the Safety and Accuracy of the Glyconics-DS in Assessment of Glycated Nail Keratin in Individuals With Unknown Diabetes Status and Performance Evaluation of the Glyconics SW Package
NCT06261944 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of SCOUT DS Device in the Diagnosis of Diabetes
NCT01634997 ·Status: UNKNOWN
-
Molecular and Clinical Profile of Diabetes Mellitus and Its Complications
NCT01105858 ·Status: SUSPENDED
-
Early Diagnosis of Diabetes Mellitus Type 2 (DM2)
NCT00469287 ·Status: COMPLETED
-
Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic Patients
NCT01538290 ·Status: COMPLETED
-
Multi-morbidity Screening in People With Type 2 Diabetes and Pre Diabetes
NCT06053177 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Iron Reduction by Phlebotomy for Type 2 Diabetes
NCT02468037 ·Status: COMPLETED ·Phase: NA
-
Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk
NCT00520962 ·Status: COMPLETED
-
Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements
NCT02028091 ·Status: COMPLETED
-
Indian Phenotype Registry
NCT03363594 ·Status: COMPLETED
-
Therapeutic Innovation in Type 2 DIABetes (IT-DIAB)
NCT01218061 ·Status: UNKNOWN ·Phase: NA
-
Metabolic Phenotypes and Heterogeneity in Disease Burden Risk in Type 1 Diabetes
NCT05609279 ·Status: COMPLETED
-
Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes
NCT01813929 ·Status: COMPLETED ·Phase: PHASE4
-
Diabetes Mellitus Type II and Tissue Oxygenation
NCT00554697 ·Status: TERMINATED
-
HbA1c Prediction Model in Patients With Type 2 Diabetes
NCT05824286 ·Status: UNKNOWN ·Phase: NA
-
Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes
NCT07039357 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Salivary Transcriptome Biomarkers for Early Diabetes Detection
NCT02673762 ·Status: UNKNOWN
-
Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.
NCT03010956 ·Status: COMPLETED
-
Heart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
NCT02996539 ·Status: COMPLETED
-
Screening and Understanding of the Pre-diabetes: DECODIAB
NCT01739868 ·Status: UNKNOWN ·Phase: NA
-
Clinical Verification of Peptide Biomarkers for Type 2 Diabetes Mellitus
NCT01902316 ·Status: COMPLETED
-
Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome
NCT05389254 ·Status: UNKNOWN ·Phase: NA
-
Capillary And Venous Accuracy: LifeScan Products vs Hospital Reference and YSI
NCT03189225 ·Status: COMPLETED ·Phase: NA